NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Sunday 1 February 2009

Neuland moves into peptides

Neuland Laboratories is making a two-step move into peptide contract manufacturing. Firstly it will establish a non-GMP facility for synthesis of peptides both for generic API and contract research opportunities. The second phase will add commercial scale GMP contract manufacturing for both generic and innovator companies.
Outsourcing Pharma

No comments: